Literature DB >> 23801824

Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.

Andrew Cassar1, Yoshiki Matsuo, Joerg Herrmann, Jing Li, Ryan J Lennon, Rajiv Gulati, Lilach O Lerman, Sudhir S Kushwaha, Amir Lerman.   

Abstract

AIMS: Cardiac allograft vasculopathy (CAV) is a major limitation to long-term survival following cardiac transplantation. Conventional imaging modalities such as angiography and intravascular ultrasound fail to characterize CAV plaque morphology. Our aim was to characterize CAV in vivo using the high spatial resolution of intracoronary optical coherence tomography (OCT). METHODS AND
RESULTS: We prospectively enrolled 53 cardiac transplant patients to undergo OCT of the left anterior descending coronary artery (LAD) in addition to annual CAV screening by coronary angiography and intravascular ultrasound (IVUS). The proximal 30 mm of the LAD was divided into three segments of 10 mm each (n = 156). Segments with CAV plaque on IVUS were analysed by OCT for specific CAV morphological characteristics within the framework of three groups according to follow-up time after heart transplantation: (i) 0-3 months (n = 18), (ii) 12-36 months (n = 55), and (iii) ≥48 months (n = 83). The prevalence of atherosclerotic characteristics such as eccentric plaques, calcification, and lipid pools increased from 6, 0, and 6% in group 1 to 78, 42, and 61% in group 3, respectively (all P < 0.001). The prevalence of vulnerable plaque features such as thin-cap fibroatheroma, macrophages, and microchannels increased from 0% in group 1 to 12, 29, and 33% in group 3, respectively (P = 0.19, P = 0.006, and P = 0.003). Complicated coronary lesions such as intimal laceration, intraluminal thrombus, and layered complex plaque increased from 0% in group 1 to 18, 19, and 57% in group 3 (P = 0.009, P < 0.001, and P < 0.001). Plaque rupture was identified in 4% of group 3 segments.
CONCLUSION: The current study gives new insight into CAV that extends far beyond the current concept of concentric and fibrosing vasculopathy, that is, the development of atherosclerosis with vulnerable plaque and complicated coronary lesions.

Entities:  

Keywords:  Atherosclerosis; Cardiac allograft vasculopathy; Optical coherence tomography; Thrombus; Transplant; Vulnerable plaque

Mesh:

Year:  2013        PMID: 23801824      PMCID: PMC3758840          DOI: 10.1093/eurheartj/eht236

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

1.  Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression.

Authors:  A P Burke; F D Kolodgie; A Farb; D K Weber; G T Malcom; J Smialek; R Virmani
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma.

Authors:  Takahiro Sawada; Junya Shite; Hector M Garcia-Garcia; Toshiro Shinke; Satoshi Watanabe; Hiromasa Otake; Daisuke Matsumoto; Yusuke Tanino; Daisuke Ogasawara; Hiroyuki Kawamori; Hiroki Kato; Naoki Miyoshi; Mitsuhiro Yokoyama; Patrick W Serruys; Ken-ichi Hirata
Journal:  Eur Heart J       Date:  2008-04-07       Impact factor: 29.983

3.  High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.

Authors:  E M Tuzcu; S R Kapadia; E Tutar; K M Ziada; R E Hobbs; P M McCarthy; J B Young; S E Nissen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

4.  Immunohistochemical characterization of coronary thrombi in allograft vascular disease.

Authors:  E Arbustini; B Dal Bello; P Morbini; A Gavazzi; G Specchia; M Viganò
Journal:  Transplantation       Date:  2000-03-27       Impact factor: 4.939

5.  Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age.

Authors:  D Velican; C Velican
Journal:  Atherosclerosis       Date:  1981 Jan-Feb       Impact factor: 5.162

6.  Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease.

Authors:  Briain D MacNeill; Ik-Kyung Jang; Brett E Bouma; Nicusor Iftimia; Masamichi Takano; Hiroshi Yabushita; Milen Shishkov; Christopher R Kauffman; Stuart L Houser; H Thomas Aretz; Denise DeJoseph; Elkan F Halpern; Guillermo J Tearney
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

7.  Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation.

Authors:  E Arbustini; B Dal Bello; P Morbini; M Grasso; M Diegoli; R Fasani; A Pilotto; O Bellini; C Pellegrini; L Martinelli; C Campagna; A Gavazzi; G Specchia; M Viganò; W C Roberts
Journal:  Am J Cardiol       Date:  1996-10-01       Impact factor: 2.778

8.  Simvastatin initiated early after heart transplantation: 8-year prospective experience.

Authors:  Klaus Wenke; Bruno Meiser; Joachim Thiery; Dorothea Nagel; Wolfgang von Scheidt; Karl Krobot; Gerhard Steinbeck; Dietrich Seidel; Bruno Reichart
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

9.  Characterization of human atherosclerosis by optical coherence tomography.

Authors:  Hiroshi Yabushita; Brett E Bouma; Stuart L Houser; H Thomas Aretz; Ik-Kyung Jang; Kelly H Schlendorf; Christopher R Kauffman; Milen Shishkov; Dong-Heon Kang; Elkan F Halpern; Guillermo J Tearney
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

Review 10.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

View more
  21 in total

1.  Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.

Authors:  Michal Pazdernik; Dan Wichterle; Zhi Chen; Helena Bedanova; Josef Kautzner; Vojtech Melenovsky; Vladimir Karmazin; Ivan Malek; Peter Stiavnicky; Ales Tomasek; Eva Ozabalova; Jan Krejci; Andreas Wahle; Honghai Zhang; Tomas Kovarnik; Milan Sonka
Journal:  Clin Transplant       Date:  2020-01-09       Impact factor: 2.863

2.  Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.

Authors:  Woong Gil Choi; Megha Prasad; Ryan Lennon; Rajiv Gulati; Abhiram Prasad; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2018-03       Impact factor: 1.439

3.  New developments for the detection and treatment of cardiac vasculopathy.

Authors:  Kevin J Clerkin; Ziad A Ali; Donna M Mancini
Journal:  Curr Opin Cardiol       Date:  2017-02-15       Impact factor: 2.161

Review 4.  How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.

Authors:  Ali Javaheri; Naveen Saha; Scott M Lilly
Journal:  Curr Heart Fail Rep       Date:  2016-04

5.  Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy.

Authors:  Bo Zheng; Akiko Maehara; Gary S Mintz; Tamim M Nazif; Yarden Waksman; Fuyu Qiu; Luz Jaquez; LeRoy E Rabbani; Mark A Apfelbaum; Ziad A Ali; Kate Dalton; Lei Song; Ke Xu; Charles C Marboe; Donna M Mancini; Giora Weisz
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-25       Impact factor: 2.357

6.  Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy.

Authors:  Ruud B van Heeswijk; Jessica A M Bastiaansen; Juan F Iglesias; Sophie Degrauwe; Samuel Rotman; Jean-Luc Barras; Julien Regamey; Nathalie Lauriers; Piergiorgio Tozzi; Jérôme Yerly; Giulia Ginami; Matthias Stuber; Roger Hullin
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-13       Impact factor: 2.357

7.  Evaluation of repeated progression of native coronary artery stenosis by optical frequency domain imaging in a patient with essential thrombocytosis.

Authors:  Hiroto Tamaru; Kenichi Fujii; Satoru Otsuji; Shin Takiuchi; Katsuyuki Hasegawa; Kasumi Ishibuchi; Rui Ishii; Wataru Yamamoto; Sho Nakabayashi; Mikio Kakishita; Motoaki Ibuki; Shinya Nagayama; Yorihiko Higashino
Journal:  J Cardiol Cases       Date:  2018-05-30

8.  Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.

Authors:  Kozo Okada; William F Fearon; Helen Luikart; Hideki Kitahara; Kyuhachi Otagiri; Shigemitsu Tanaka; Takumi Kimura; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; Hannah A Valantine; Kiran K Khush; Yasuhiro Honda
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

9.  Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients.

Authors:  Hideki Kitahara; Kozo Okada; Shigemitsu Tanaka; Hyoung-Mo Yang; Kojiro Miki; Yuhei Kobayashi; Takumi Kimura; Helen Luikart; Paul G Yock; Alan C Yeung; Peter J Fitzgerald; Kiran K Khush; William F Fearon; Yasuhiro Honda
Journal:  J Heart Lung Transplant       Date:  2016-03-10       Impact factor: 10.247

Review 10.  Cholesterol efflux in the transplant patient.

Authors:  Sangita Sudharshan; Ali Javaheri
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.